| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V61989 | MurA-IN-1 | 354815-90-0 | MurA-IN-1 (compound 1a) is an inhibitor (blocker/antagonist) of PTPRR, with IC50s of 0.23 μM, 0.8 μM, 0.75 μM and 0.09 μM for PTP1B, PTPN5, PTPN7 and PTPRR, respectively. |
|
V58054 | MurB-IN-1 | 2883232-46-8 | MurB-IN-1 (compound 44) is an inhibitor (blocker/antagonist) of UDP-N-ethynyl acetonylglucosamine reductase (MurB) with a Kd of 3.57 μM. |
|
V59108 | MurF-IN-1 | 303790-97-8 | MurF-IN-1 (Compound 7) is a MurF inhibitor (antagonist) with pIC50 of 5.19 against S. pneumoniae MurF. |
|
V64397 | MuRF1-IN-1 | 445222-91-3 | MuRF1-IN-1 is a MuRF1 inhibitor that reduces skeletal muscle atrophy and dysfunction in cardiac cachexia. |
|
V59193 | MuRF1-IN-2 | 937891-74-2 | MuRF1-IN-2 (Example 3) is a MuRF1 inhibitor. |
|
V58554 | Mutanolysin | 55466-22-3 | Mutanolysin is a biochemical compound that can be used as a biomaterial or organic/chemical reagent for biomedical research. |
|
V64318 | Muvalaplin (LY3473329) | 2565656-70-2 | Muvalaplin (LY3473329) is an orally bioactive lipoprotein(a) Lp(a) agent. |
|
V74881 | Muzastotug | 2750031-18-4 | Muzastotug is a humanized immunoglobulin G1-kappa, anti-CTLA4 monoclonal antibody (mAb). |
|
V64298 | MYF-03-176 | 2857937-59-6 | MYF-03-176 is an orally bioactive anticancer agent. |
|
V60055 | myo-Inositol dehydrogenase | 9028-25-5 | myo-Inositol dehydrogenase is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
|
V59182 | myo-Inositol trispyrophosphate hexa-triethylamine (ITPP hexa-triethylamine) | 851086-77-6 | myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine is an inositol trispyrophosphate (ITPP) salt that is a membrane-penetrating allosteric effector of hemoglobin. |
|
V64491 | myo-Inositol trispyrophosphate hexasodium (ITPP hexasodium) | 23103-35-7 | Myo-Inositol trispyrophosphate (ITPP) hexasodium is a hemoglobin (haemoglobin) modulator and an allosteric effector that reduces the oxygen-binding affinity of hemoglobin and promotes oxygen release from red blood cells. |
|
V57923 | Myoferlin inhibitor 1 | 2366279-99-2 | Myoferlin inhibitor 1 is a novel molecule with anti-pancreatic cancer metastasis activity by targeting myosin. |
|
V60611 | Myristoyl-L-carnitine chloride | 173686-73-2 | Myristoyl-L-carnitine chloride is a naturally occurring long-chain acylcarnitine, an amino acid (AA) analogue. |
|
V64468 | Myt1-IN-1 | 2719749-02-5 | Myt1-IN-1 is a potent Myt1 inhibitor (antagonist) with IC50 <10 nM. |
|
V62569 | Myt1-IN-2 | 2719748-43-1 | Myt1-IN-2 is a potent Myt1 inhibitor (antagonist) with IC50 <10 nM. |
|
V62035 | Myt1-IN-3 | 2719793-54-9 | Myt1-IN-3 is a potent Myt1 inhibitor (antagonist) with IC50 of less than 10 nM (WO2021195782 A1, compound 95). |
|
V58575 | N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) | 140-79-4 | N,N'-Dinitrosopiperazine (1,4-Dinitrosopiperazine; DNP) is a carcinogen that is specific for nasopharyngeal cancer and can promote the metastasis of nasopharyngeal cancer. |
|
V61859 | N,N,N′,N′-Tetracyclohexyl-3-oxapentanediamide (Calcium ionophore II) | 74267-27-9 | N,N,N′,N′-Tetracyclohexyl-3-oxapentanediamide (Calcium ionophore II) is a lipophilic ionophore that may be utilized to prepare calcium ion selective electrodes. |
|
V61828 | N,N,N′,N′-Tetramethyl-p-phenylenediamine | 100-22-1 | N,N,N′,N′-Tetramethyl-p-phenylenediamine (TMPD) is a redox indicator. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
